Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352

European Journal of Pharmacology

Volumn 437, Issue 3, 2002, Pages 129-137

  Dupuis, Delphine S ^a   Schroder, Rikke L ^b,c   Jespersen, Thomas ^a   Christensen, Jeppe K ^b   Christophersen, Palle ^b   Jensen, Bo S ^b   Olesen, Soren P ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEUROSEARCH A S   (Denmark)

^c University ^*  (Denmark)

Author keywords

Linopirdine; M channel; M current; XE 991

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9 (10H)ANTHRACENONE; 10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; 3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; LINOPIRDINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RETIGABINE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; M CURRENT; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS;

ANTHRACENES; CARBAMATES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; INDOLES; KCNQ POTASSIUM CHANNELS; MEMBRANE POTENTIALS; PHENYLENEDIAMINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PYRIDINES;

EID: 18344363352     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01287-6     Document Type: Article

References (35)

1. KvLQT1 and IsK (minK) proteins associate to form the Iks cardiac potassium current
2. A potassium channel mutation in neonatal human epilepsy
3. M current
4. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family
5. The maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury
6. Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias
7. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families
8. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels
9. Neuronal KCNQ potassium channels: Physiology and role in disease
10. Molecular genetic insights into cardiovascular disease
11. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway
12. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated i dominant deafness
13. Effects of a cognition-enhancer, linopirdine (DuP 996), on M-type potassium currents (IK(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons
14. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity
15. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine
16. Control of M-current
17. D-23129: A new anticonvulsant with broad spectrum activity in animal models of epileptic seizures
18. The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells
19. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits
20. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia
21. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac Iks potassium channel
22. KCNQ4 channel activation by BMS-204352 and retigabine
23. KCNQ5, a novel potassium channel broadly expressed in brain mediates M-type currents
24. Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors
25. Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current
26. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
27. KCNQ4 channels expressed in mammalian cells: Functional characteristics and pharmacology
28. The IKs channel: Coassembly of IsK (minK) and KvLQT1 proteins
29. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine
30. The KCNQ2 potassium channel: Splice variants, functional and developmental expression. Brain localization and comparision with KCNQ3
31. KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlations of the M-channel
32. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channel
33. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
34. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias
35. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy